AI is moving across particle therapy planning but clinical validation remains the bottleneck
AI can automate particle planning, dose prediction, adaptation and quality assurance, but limited data and validation still constrain clinical adoption.
AI can automate particle planning, dose prediction, adaptation and quality assurance, but limited data and validation still constrain clinical adoption.
A model integrating planning CT, 3D dose and tumor contours achieved strong external prediction of distant metastasis but weaker local-recurrence performance.
ASTuTE biomarker testing changed 27.5% of shared decisions and reduced planned short-term ADT use from 37% to 12.5%.
A scoping review maps generative AI across imaging, documentation, QA and decision support while emphasizing major safety and governance gaps.
AI synthetic CT preserved soft-tissue HU and geometry well, while bone, air interfaces and implanted devices remained important failure modes.
Reference-free LLM planning improved hotspot control and boost-target conformity while maintaining organ-at-risk sparing comparable to clinical plans.
An open-source workflow structured 15 years of radiotherapy data, although reirradiation prediction showed only modest discrimination.
The Transformer calculated carbon-ion pencil-beam doses in 14 milliseconds with 98.0% gamma agreement at stringent 1%/1 mm criteria.
AI-assisted planning cut average planning time from about two hours to 30 minutes, but three of 12 plans required manual hotspot correction.
Patient-specific reinforcement learning improved moving-target coverage over static GTV plans while reducing some normal-tissue exposure compared with ITV planning.
A retrieval-augmented GPT-4.1 chatbot rapidly surfaced previous TrueBeam faults, but procedural, role-definition and safety errors remained.
Thoracic AI contours showed strong geometric and dosimetric agreement, but physicians still rejected some heart and oesophageal contours.
A center-specific federated learning model predicted grade 2 or higher radiation pneumonitis with stable cross-dataset performance.
Artificial intelligence planning produced clinically acceptable whole-brain radiotherapy plans in 14 of 15 independent test cases.
An artificial intelligence coronary artery surrogate strongly correlated with manual dose metrics in simulated lung stereotactic body radiotherapy.